Nonclinical efficacy and toxicity study of GMP-grade vector OPGx-RHO (scAAV2/5-RHO820-shRNA820) delivered by subretinal injection in a canine model of RHO-adRP
Safety and Efficacy of OPGx-RHO Silence-and-Replace Gene Therapy for RHO-adRP: Evidence Across Two Large Animal Models
Nonclinical Efficacy and Toxicity Study of GMP-Grade Vector OPGx-RHO (Scaav2/5-RHO820-Shrna820) Delivered by Subretinal Injection in a Canine Model of RHO-adRP
Therapeutic Efficacy of a Mutation-Independent AAV Knockdown and Replacement Approach in a Swine Animal Model of Autosomal-Dominant Retinitis Pigmentosa (adRP)
Preliminary Results from Adult Participant in a Phase 1b/2a Clinical Study of OPGx-BEST1 Gene Therapy for ARB and BVMD Due to BEST1 Mutations
Phentolamine Ophthalmic Solution Demonstrates Prolonged Duration of Action with Improvement in Distance-Corrected Near Vision for Presbyopic Patients in a Phase 3 Study
Phase 3 Randomized Controlled Study of Phentolamine Ophthalmic Solution in Post-Refractive Surgery Patients with Impaired Mesopic Vision
